Access the Medical Office Investment—Series 2

Webinar Recording

Get exclusive access to the Medical Office Investment Webinar recording and discover how you can invest in high-performing medical office properties.
Investment Highlights:

8% Preferred Return – Stable cash flow with priority distributions
16-20% Targeted IRR – With potential 25-35% upside
✅ 2 to 3x targeted equity multiple with a 5-year hold period 
Monthly Distributions – Starting 90 days post-closing
✅ Minimal Management – Triple-net leases reduce investor responsibilities
✅ Tax Benefits – Estimated $50K Year 1 deductions on a $100K investment

Access the

Medical Office Investment—Series 2

Webinar Recording

Get exclusive access to the Medical Office Investment Webinar recording and discover how you can invest in high-performing medical office properties.

Investment Highlights:

8% Preferred Return – Stable cash flow with priority distributions
16-20% Targeted IRR – With potential 25-35% upside
✅ 2 to 3x targeted equity multiple with a 5-year hold period
Monthly Distributions – Starting 90 days post-closing
Minimal Management – Triple-net leases reduce investor responsibilities
Tax Benefits – Estimated $50K Year 1 deductions on a $100K investment

Timberview Capital does not provide legal, tax, investment, or financial advice; content on this site is informational and of a general nature. Nothing on this site is an offer to sell or a solicitation of an offer to buy any security. Offers are made only to verified accredited investors pursuant to Rule 506(c) of Regulation D, through a private placement memorandum and related offering documents. All investments involve risk, including loss of principal. Projected or targeted returns are estimates only, are not guaranteed, and may not be achieved; past performance does not guarantee future results. Private placements are illiquid, and distributions are not guaranteed. Testimonials reflect individual experiences and are not representative of all investors. Hyperlinks to third-party content are not endorsements. Please review all offering materials and consult your own advisors before investing.